TIME ponders whether Vytorin is a failure:
In the meantime, doctors are likely to dial back on their use of Vytorin. “If they aren’t getting to the target goal [cholesterol level] with generic simvastatin, then because this study is raising questions I think a lot of physicians will think about switching to higher doses of drugs like Lipitor or Crestor before going to Vytorin.”
